Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      November 4, 2026
      Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
      Biotech

      Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement

      November 3, 2026
      argenx to Present at Upcoming Investor Conferences
      Biotech

      argenx to Present at Upcoming Investor Conferences

      November 3, 2026
      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
      Biotech

      Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation

      November 2, 2026
      Mesoblast Board Changes
      Biotech

      Mesoblast Board Changes

      November 2, 2026
      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
      Biotech

      HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

      November 2, 2026
      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
      Biotech

      Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE

      October 31, 2026
      Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
      Biotech

      Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

      October 30, 2026
      Fortrea Reports Third Quarter 2026 Results
      Biotech

      Fortrea Reports Third Quarter 2026 Results

      October 29, 2026
      Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
      Biotech

      Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

      October 29, 2026
      « 1 2 3 4 … 91 »

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2026